Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EV71 vaccine coadministration with pediatric vaccines
CTR20180568Phase 4Completed
- Sponsor
- Wuhan Institute of Biological Products
- Start
- May 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Inactivated Enterovirus Type 71 Vaccine (Vero Cell) in hepatitis B (HBV), meningococcal meningitis, measles, rubella, Japanese encephalitis (JE), sponsored by Wuhan Institute of Biological Products. Started May 2018; status: completed.
02
Drugs
Inactivated Enterovirus Type 71 Vaccine (Vero Cell)
03
Conditions
hepatitis B (HBV)meningococcal meningitismeaslesrubellaJapanese encephalitis (JE)
Beyond the preview
Go deeper on CTR20180568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180568.